Trimethylamine Oxidation into the Proatherogenic Trimethylamine N-Oxide Is Higher in Coronary Heart Disease Men: From the CORDIOPREV Study
	    		
		   		
		   			
		   		
	    	
    	- Author:
	        		
		        		
		        		
			        		Helena GARCIA-FERNANDEZ
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Juan F. ALCALA-DIAZ
			        		
			        		;
		        		
		        		
		        		
			        		Gracia M. QUINTANA-NAVARRO
			        		
			        		;
		        		
		        		
		        		
			        		Javier LOPEZ-MORENO
			        		
			        		;
		        		
		        		
		        		
			        		Diego LUQUE-CORDOBA
			        		
			        		;
		        		
		        		
		        		
			        		Eugenia Ruiz-Diaz NARVAEZ
			        		
			        		;
		        		
		        		
		        		
			        		Antonio P. Arenas-de LARRIVA
			        		
			        		;
		        		
		        		
		        		
			        		Francisco M. GUTIERREZ-MARISCAL
			        		
			        		;
		        		
		        		
		        		
			        		Jose D. TORRES-PEÑA
			        		
			        		;
		        		
		        		
		        		
			        		Diego RODRIGUEZ-CANO
			        		
			        		;
		        		
		        		
		        		
			        		Raul M. LUQUE
			        		
			        		;
		        		
		        		
		        		
			        		Feliciano PRIEGO-CAPOTE
			        		
			        		;
		        		
		        		
		        		
			        		Jose LOPEZ-MIRANDA
			        		
			        		;
		        		
		        		
		        		
			        		Antonio CAMARGO
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Original Article
 - From:The World Journal of Men's Health 2025;43(1):249-258
 - CountryRepublic of Korea
 - Language:English
 - 
		        	Abstract:
			       	
			       		
				        
				        	 Purpose:Cardiovascular disease (CVD) is more prevalent in men than women, but the mechanisms responsible for this are not fully understood. We aimed to evaluate differences in trimethylamine (TMA), a microbial metabolite and its oxidized form, trimethylamine N-oxide (TMAO), which is thought to promote atherosclerosis, between men and women with coronary heart disease (CHD), using as a reference a non-CVD population. 
				        	
Materials and Methods:This study was carried out within the framework of the CORDIOPREV study (NCT00924937; June 19, 2009), a clinical trial which included 827 men and 175 women with CHD, with a non-CVD population of 375 individuals (270 men and 105 women) as a reference group. Plasma TMA and TMAO were measured by HPLC-MS/MS. The carotid study was ultrasonically assessed bilaterally by the quantification of intima-media thickness of both common carotid arteries (IMT-CC).
Results:We found higher TMAO levels and TMAO/TMA ratio in CHD men than CHD women (p=0.034 and p=0.026, respectively). No TMA sex differences were found in CHD patients. The TMA and TMAO levels and TMAO/TMA ratio were lower, and no differences between sexes were found in the non-CVD population. TMAO levels in CHD patients were consistent with higher IMT-CC and more carotid plaques (p=0.032 and p=0.037, respectively) and lower cholesterol efflux in CHD men than CHD women (p<0.001).
Conclusions:Our results suggest that CHD men have augmented TMAO levels compared with CHD women, presumably as a consequence of higher rate of TMA to TMAO oxidation, which could be associated with CVD, as these sex differences are not observed in a non-CVD population. 
            